Natural history of untreated prostate specific antigen radiorecurrent prostate cancer in men with favorable prognostic indicators.
Ontology highlight
ABSTRACT: Background and Purpose. Life expectancy data could identify men with favorable post-radiation prostate-specific antigen (PSA) failure kinetics unlikely to require androgen deprivation therapy (ADT). Materials and Methods. Of 206 men with unfavorable-risk prostate cancer in a randomized trial of radiation versus radiation and ADT, 53 experienced a PSA failure and were followed without salvage ADT. Comorbidity, age and established prognostic factors were assessed for relationship to death using Cox regression analyses. Results. The median age at failure, interval to PSA failure, and PSA doubling time were 76.6 years (interquartile range [IQR]: 71.8-79.3), 49.1 months (IQR: 37.7-87.4), and 25 months (IQR: 13.1-42.8), respectively. After a median follow up of 4.0 years following PSA failure, 4
SUBMITTER: Martin NE
PROVIDER: S-EPMC3950926 | biostudies-literature | 2014
REPOSITORIES: biostudies-literature
ACCESS DATA